addiction

MindMed sets milestone in finding psychedelic cure for opioid addiction

The company has come up with a derivative of ibogaine, a psychoactive substance from an African shrub.

0

Awakn Life Sciences starts study on ketamine treatment for gambling addiction

Toronto-based biotechnology company Awakn has a research program on ketamine-assisted psychotherapy against multiple addictions.

0

Growing body of research shows patients with addiction, PTSD, and depression can benefit from psychedelic substances

Numinus Wellness chief medical officer Dr. Evan Wood cautions that it’s not a cure for everybody—but trials have shown statistically significant results

0